HGH 191AA refers to human growth hormone with a chain of 191 amino acids. Somatropin is the recombinant version used in prescription growth hormone medicines. The number describes the molecule, not a special strength or a new class of supplement. [1]
Growth hormone replacement has medical evidence in selected patients. That doesn’t establish the broader muscle, recovery and anti-aging promises often attached to the HGH 191AA name.
HGH 191AA vs HGH: what is the difference?
Human growth hormone, also called GH or somatotropin, is produced by the pituitary gland. The familiar 191-amino-acid form is a polypeptide, meaning a chain of amino acids. Somatropin is made using recombinant DNA technology; its amino acid sequence matches this natural hormone. [1] GENOTROPIN is one example of a prescription somatropin product. [2]
So “HGH 191AA vs HGH” is usually not a comparison between two fundamentally different hormones. The more important question is which actual product or molecule is being discussed?
| Name | What it means and limits |
|---|---|
| HGH 191AA / somatropin | The 191-amino-acid growth hormone sequence. Keep in mind: A sequence name is not proof that a particular vial is an approved medicine. [1][2] |
| Somatrem / 192AA | An earlier recombinant form with an additional amino acid, methionine. Keep in mind: This historical naming difference does not establish the quality of a modern research product. [3] |
| A named prescription product | A specific formulation with its own approved labeling. Keep in mind: Indication, device, preparation instructions and storage belong to that product. [2] |
For example, a label saying “10 IU vial” describes a claimed amount of activity. It does not tell you whether that product has been verified as sterile, whether it contains what it claims, or whether it is appropriate for a particular person. Do not read the amino acid count as a quality certificate.
What benefits does the evidence support?
Start with the population being studied. An adult with confirmed growth hormone deficiency is not the same as a healthy adult seeking fat loss. The Endocrine Society describes potential improvements in body composition, exercise capacity, bone health and quality of life with replacement in adults who have GHD. Confirming the diagnosis usually requires stimulation testing, with exceptions for certain established causes. [4]
A low energy level, an age-related hormone change or an internet symptom checklist does not establish that diagnosis. A clinician needs to decide whether testing is appropriate and how the results fit the person’s history.
| Evidence | Finding and limits |
|---|---|
| Adults with diagnosed GHD | Specialist guidance supports replacement for selected patients, with individualized benefits and risks. [4] Keep in mind: This is treatment of a medical deficiency, not evidence that everyone benefits from more GH. |
| Healthy older adults: 2007 systematic review | Small changes in body composition, including less fat mass and more lean mass, accompanied by increased adverse events. [5] Keep in mind: The authors did not recommend GH as an anti-aging treatment. The studies were small and relatively short. |
| 96 recreational athletes: 2010 randomized trial | Sprint capacity improved, but other tested performance measures did not significantly improve. Increased lean mass included extracellular water. [6] Keep in mind: Lean mass is not the same as stronger muscle. This trial did not establish long-term safety. |
This is why a before-and-after scan or a claim about “anabolic effects” is not enough. Ask what changed: water, fat mass, strength, symptoms or a meaningful health outcome. Those are different endpoints.
Quick check: does more lean mass mean more muscle strength?
No. Lean mass includes body water and other non-fat tissue. In the recreational-athlete trial, changes in body composition did not translate into broad improvements across performance tests. Read the measured outcome, not just the headline. [6]
HGH 191AA side effects and monitoring
Somatropin can cause fluid retention, swelling, joint or muscle pain and nerve-compression symptoms such as carpal tunnel syndrome. It can also reduce insulin sensitivity. Prescription labeling warns about glucose problems and intracranial hypertension, among other risks. Severe headache or visual changes during treatment need prompt medical assessment. [2]
Active malignancy and certain forms of acute critical illness are among the contraindications in the GENOTROPIN label. This is not a complete screening list. The prescribing clinician must consider the specific product, medical history and other medicines. [2]
Adult replacement is adjusted to the individual rather than taken from a bodybuilding cycle. Follow-up may include symptoms, side effects and IGF-1, an important marker in the growth hormone system. The aim is to assess an appropriate clinical response, not chase the highest laboratory number. [4]
IU, syringe units and reconstitution are different questions
Three labels can appear in the same discussion, but they describe different things:
- IU: a measure of biological activity.
- mg: a measure of mass.
- mL: a measure of liquid volume.
A syringe marking does not tell you the amount of somatropin unless the concentration is known. An insulin syringe’s volume markings are not HGH IU. Likewise, “reconstitute” means preparing a solution from a powder, not choosing a medically appropriate dose.
Use the instructions supplied with the exact prescription formulation for preparation, refrigeration and disposal. Do not transfer a research-vial mixing example to a cartridge or pen. The related resources below explain terminology and calculations; they do not establish that a product or schedule is suitable for you.
Common questions
Is HGH 191AA FDA-approved?
Specific somatropin medicines have approved uses. “HGH 191AA” printed on an arbitrary research vial does not confer that approval. GENOTROPIN’s indications include adult GHD and selected pediatric growth disorders, not general rejuvenation. [2]
Can healthy adults use it for anti-aging or fat loss?
Changes in body fat do not establish an anti-aging benefit. The systematic review in healthy older adults found limited benefits with more adverse events. It does not support treating normal aging with GH. [5]
Is it permitted in competitive sport?
Under the 2026 WADA Prohibited List, growth hormone is prohibited at all times. Athletes who need a prescribed treatment should consult their anti-doping organization about the applicable therapeutic-use exemption process. [7]
Bottom line: the meaningful distinction is not “191AA” versus a more impressive-sounding label. It is a verified medicine used for a defined condition versus an unsupported promise. Discuss possible deficiency or treatment questions with a qualified healthcare professional.
Related dosage protocols and research
Explore related research, dosage references and guides below. Vial strengths have separate references because concentration and syringe-unit calculations differ. A comparison does not mean the compounds are interchangeable.
Matching dosage protocols
Further research context
References
- National Library of Medicine: Human Growth Hormone, MeSH definition.
- GENOTROPIN (somatropin): prescribing information. DailyMed.
- Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review. 2011.
- Endocrine Society: Evaluation and Treatment of Adult Growth Hormone Deficiency. Clinical practice guideline, 2011.
- Liu et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine, 2007.
- Meinhardt et al. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Annals of Internal Medicine, 2010.
- World Anti-Doping Agency: 2026 Prohibited List, S2.